Takara Bio Usa, Inc.
San Jose, CA
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2560 Orchard Pkwy, San Jose, CA 95131, USA
- Website
- takarabio.com
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $67,363 |
| FY2025 | $48,587 |
| FY2024 | $179,355 |
| FY2023 | $84,035 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $67,363 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Invivoscribe, Inc. | San Diego, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Biolegend, Inc. | San Diego, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Life Science Group | Hercules, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Mission Bio, Inc. | South San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Proteinsimple | San Jose, CA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Takara Bio Usa, Inc., doing business as Takara Bio USA, is a San Jose, California-based for-profit manufacturer of biomedical products and life sciences research tools that sells reagents, kits, instruments, and maintenance services to federal research agencies exclusively as a prime contractor (100% of awards). The company competes full-and-open across its prime footprint with no set-aside designations on the majority of work; one Total Small Business set-aside purchase order appears in recent awards. Takara Bio USA has held federal contracts since at least 2001 and operates across primary NAICS codes centered on biological product manufacturing (179 awards), analytical laboratory instrument manufacturing (31 awards), and in-vitro diagnostic substance manufacturing (17 awards).
The customer base concentrates heavily within the National Institutes of Health and related HHS research components. The National Cancer Institute leads by both award count and dollar value (44 awards, $1.1 million combined potential value), followed by the NIH Clinical Center (16 awards, $804 thousand), the National Institute of Allergy and Infectious Diseases (18 awards, $336 thousand), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (7 awards, $311 thousand), and the Environmental Protection Agency's Office of Research and Development (14 awards, $225 thousand). These five customers account for 60% of combined potential value across the entire award portfolio. Representative recent work includes a $26,816 maintenance contract for a Becton Dickinson 3-laser FACSLyric flow cytometer at the NIH Clinical Center (June 2026), a $24,601 purchase order from the NIH Clinical Center for RetroNectin GMP grade reagent to support cellular therapy manufacturing (May 2026), and a $35,232 delivery of SmartScribe Reverse Transcriptase and SeqAmp DNA kits to the National Institute of Allergy and Infectious Diseases (June 2024). Historical work includes COVID-19 research support through reverse transcriptase and reagent procurements from NIAID beginning in 2021.
Activity has declined moderately over the past five years: six awards in 2022, five each in 2023 and 2024, three in 2025, and three thus far in 2026. The combined potential value across all 570 prime awards totals $4.7 million with $4.6 million obligated (99% of ceiling). Only two awards with completion dates in the next twenty-four months carry combined potential value of $43 thousand, representing minimal near-term recompete exposure. Takara Bio USA holds task order positions under at least three parent vehicles: an NIH indefinite delivery contract (HHSN261201400019I) with five task orders worth $127 thousand, and two additional IDCs and blanket purchase agreements with lower activity. The company operates no subcontract relationships in federal work; 100% of its federal footprint consists of prime contractor roles supplying reagents, kits, and services directly to government research facilities.
Quick answers
Is Takara Bio Usa, Inc. registered in SAM.gov?
Yes. Takara Bio Usa, Inc.'s SAM.gov registration is active through August 27, 2027.
What is Takara Bio Usa, Inc.'s CAGE code?
Takara Bio Usa, Inc.'s CAGE code is 0PAF1, and its Unique Entity ID (UEI) is SCQNFFL3RJD9.
How much has Takara Bio Usa, Inc. received in federal contracts?
Federal contracts obligated $48,587 to Takara Bio Usa, Inc. in fiscal year 2025 and $379,340 in fiscal years 2023 through 2027.
How does Takara Bio Usa, Inc. rank among federal contractors?
Takara Bio Usa, Inc. ranked #88 in NAICS 325414 in FY2025.
What is Takara Bio Usa, Inc.'s most recent federal award?
Takara Bio Usa, Inc.'s most recent federal contract award is Niaaa: supply: takara BIO seeker reagents: N/a (75N98026P00754), from Office of Logisitics and Acquisition Operations (NIH), on June 15, 2026.
On GovTribe
See Takara Bio Usa, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors